News

New Release – Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

New Release – Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

Novel Adaptive Superiority Trial Design of ProtEmbo® Cerebral Embolic Protection (CEP) System
Read More
News Release – Professor J Mocco to Join Protembis’ Board of Directors

News Release – Professor J Mocco to Join Protembis’ Board of Directors

Protembis announces the appointment of Professor J. Mocco to Board of Directors
Read More
News Release – Azin Parhizgar As New Chairwoman of Protembis

News Release – Azin Parhizgar As New Chairwoman of Protembis

Azin Parhizgar To Chair Protembis’ New Board of Directors
Read More
News Release – EU Clinical Study

News Release – EU Clinical Study

Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System Enrollment with advanced...
Read More
News Release – Special Report First-in-Human 2nd Generation
News Release – Series A Financing

News Release – Series A Financing

Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing
Read More
News Release – ISO 13485:2016

News Release – ISO 13485:2016

Protembis Achieves ISO 13485:2016 Quality Management System Certification
Read More
News Release – First in Human

News Release – First in Human

Protembis announces successful first-in-human use of its ProtEmbo®Cerebral Protection System in European trial
Read More
News Release – German Accelerator Life Sciences

News Release – German Accelerator Life Sciences

Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion
Read More
News Release – Seed Financing

News Release – Seed Financing

Medical device company Protembis GmbH has closed its seed financing round
Read More